ROBBIE LEINART: Open Payments
NPI 1770617011 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,838 in 60 payments from 9 companies in 2025. Trend: 2023 $3,539 · 2024 $17,278 · 2025 $12,838
Speaker / faculty: $12,035Food & beverage: $657Travel & lodging: $146
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 40 | $11,030 |
| ABBVIE INC. | 10 | $1,601 |
| Janssen Biotech, Inc. | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $25 |
| PFIZER INC. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $14 |
Products named: VOQUEZNA, CREON, TREMFYA, XIFAXAN, SKYRIZI, RINVOQ, DUPIXENT, REZDIFFRA.
Industry payments across TN — which companies pay providers there.
